Severe graft-versus-host disease and limited durable response with mogamulizumab for post-transplant relapse of adult T-cell leukemia/lymphoma

Transplantation and Cellular Therapy · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles